Empaglin Duo Tablet 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
MFDS item code 202302757 · Approved 2023.09.14
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to assist in blood glucose control in adults with type 2 diabetes. It is particularly suitable for patients whose blood glucose control has been inadequate. It can also be used in patients with type 2 diabetes who have cardiovascular diseases, but the clinical trial information and precautions from professionals should be referred to upon use. This medication effectively controls blood glucose and assists in diabetes management.
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take the same doses of empagliflozin and metformin as before. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the initial dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication helps control blood glucose and is used for diabetes treatment. However, during its use, a rare complication called lactic acidosis may occur, so caution is advised. Lactic acidosis is a serious condition that arises when too much lactic acid accumulates in the body, with symptoms including fatigue, muscle pain, difficulty breathing, and abdominal pain. This medication should not be administered to patients with poor kidney function, acute infections, dehydration, or severe heart disease. Additionally, it is also advised that patients with type 1 diabetes or women who are pregnant or nursing do not use this medication for safety. When used alongside other diabetes treatments, hypoglycemia may occur, so dosage adjustment is necessary if insulin or sulfonylurea medications are taken together. During treatment, regular monitoring of kidney function is essential to ensure the safe use of the medication. This medication may cause side effects such as urinary tract infections, genital infections, and increased urination, so if symptoms appear, consult with a doctor. Also, gastrointestinal disturbances, liver function abnormalities, hypoglycemia, fluid loss, and other adverse reactions have been reported, so caution is required. Prior to surgery or radiological examinations, this medication should be temporarily halted, and after confirming normal kidney function following the examination, it can be resumed. Alcohol consumption should be avoided as it may increase the risk of lactic acidosis. Elderly patients or those at risk for fluid loss should use this medication with increased caution and require regular health assessments. Women who are pregnant or may become pregnant and those who are nursing should not take this medication. In case of overdose, seek immediate medical attention for proper treatment, which may include hemodialysis. This medication is not recommended for children and should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
Brownish-purple, bilaterally convex oval film-coated tablet
10 tablets/box [(10 tablets/PTP×1)], 60 tablets/box [(10 tablets/PTP×6)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.